| pubmed-article:21474644 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21474644 | lifeskim:mentions | umls-concept:C0024115 | lld:lifeskim |
| pubmed-article:21474644 | lifeskim:mentions | umls-concept:C0392164 | lld:lifeskim |
| pubmed-article:21474644 | lifeskim:mentions | umls-concept:C1704259 | lld:lifeskim |
| pubmed-article:21474644 | lifeskim:mentions | umls-concept:C1705987 | lld:lifeskim |
| pubmed-article:21474644 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:21474644 | pubmed:dateCreated | 2011-7-18 | lld:pubmed |
| pubmed-article:21474644 | pubmed:abstractText | Cystic fibrosis (CF) is characterized by bronchoalveolar neutrophilia and submucosal lymphocytosis. We hypothesized that Th17 lymphocytes are part of this submucosal infiltrate. | lld:pubmed |
| pubmed-article:21474644 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21474644 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21474644 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21474644 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:21474644 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21474644 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:21474644 | pubmed:issn | 1535-4970 | lld:pubmed |
| pubmed-article:21474644 | pubmed:author | pubmed-author:BrownSarahS | lld:pubmed |
| pubmed-article:21474644 | pubmed:author | pubmed-author:LloydClare... | lld:pubmed |
| pubmed-article:21474644 | pubmed:author | pubmed-author:BushAndrewA | lld:pubmed |
| pubmed-article:21474644 | pubmed:author | pubmed-author:DaviesJane... | lld:pubmed |
| pubmed-article:21474644 | pubmed:author | pubmed-author:RegameyNicola... | lld:pubmed |
| pubmed-article:21474644 | pubmed:author | pubmed-author:TanHui-LengHL | lld:pubmed |
| pubmed-article:21474644 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21474644 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21474644 | pubmed:volume | 184 | lld:pubmed |
| pubmed-article:21474644 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21474644 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21474644 | pubmed:pagination | 252-8 | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:meshHeading | pubmed-meshheading:21474644... | lld:pubmed |
| pubmed-article:21474644 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21474644 | pubmed:articleTitle | The Th17 pathway in cystic fibrosis lung disease. | lld:pubmed |
| pubmed-article:21474644 | pubmed:affiliation | Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, London, UK. hlt20@doctors.org.uk | lld:pubmed |
| pubmed-article:21474644 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21474644 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21474644 | lld:pubmed |
